Cencora | COR - Sales Revenues


Cencora reported $78.4B in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
Ambu A/S DKK 1.57B 10M Mar/2026
Amplifon EUR 579.9M 72.1M Mar/2026
Apollo Hospitals Enterprise Ltd INR 64.64B 130M Mar/2026
Avanos Medical USD 182.2M 1.3M Mar/2026
Brookdale Senior Living USD 764.86M 10.77M Mar/2026
Cencora USD 78.4B 7.53B Jun/2026
Coloplast 7.04B 83M Dec/2025
Convatec Group USD 1.26B 80M Dec/2025
Diasorin EUR 292.51M 2.49M Mar/2026
Encompass Health USD 1.59B 50M Mar/2026
Enovis USD 589M 13.3M Mar/2026
GE HealthCare Technologies USD 5.13B 567M Mar/2026
Gulf Medical Proj AED 213.77M 25.43M Dec/2025
Hoya 248.13B 3.43B Mar/2026
Med Life RON 853M 65.04M Mar/2026
Oriola-kd EUR 49.8M 452.2M Mar/2026
Pediatrix Medical Group USD 493.77M 896K Dec/2025
Rede D'or Sao Luiz BRL 14.56B 180M Mar/2026
Siemens Healthineers EUR 5.68B 280M Mar/2026
Solventum Corp USD 2.01B 20M Mar/2026
Sonova Holding CHF 1.82B 216.8M Dec/2025
Supermax Corporation Bhd MYR 126.8M 60.64M Mar/2026
Veradigm USD 142.52M 9.38M Dec/2022
Zimmer Biomet Holdings USD 2.09B 150M Mar/2026